Effects of tumor necrosis factor-α inhibitors on lung lesions with rheumatoid arthritis

被引：4
|
作者：
Inoue, KI
Takano, H
Yanagisawa, R
Yoshikawa, T
机构：
[1] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan
[2] Kyoto Prefectural Univ Med, Kyoto, Japan
来源：
CHEST | 2003年 / 124卷 / 01期
关键词：
D O I：
10.1016/S0012-3692(15)36047-5
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：413 / 414
页数：2
相关论文
共 50 条
  • [11] Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: Effects of tumor necrosis factor-α blockade
    Ingegnoli, Francesca
    Fantini, Flavio
    Favalli, Ennio Giulio
    Soldi, Amedeo
    Griffini, Samantha
    Galbiati, Valentina
    Meroni, Pier Luigi
    Cugno, Massimo
    JOURNAL OF AUTOIMMUNITY, 2008, 31 (02) : 175 - 179
  • [12] Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors
    Chakravarty, EF
    Michaud, K
    Wolfe, F
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (11) : 2130 - 2135
  • [13] The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis
    Kavanaugh, A
    Cohen, S
    Cush, JJ
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (10) : 1881 - 1884
  • [14] Inhibitors of tumor necrosis factor in rheumatoid arthritis: Will that dog hunt?
    Kavanaugh, A
    Cohen, S
    Cush, J
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (11) : 2049 - 2053
  • [15] Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis
    Nilsson, Anna Christine
    Christensen, Anne Friesgaard
    Junker, Peter
    Lindegaard, Hanne Merete
    DANISH MEDICAL BULLETIN, 2011, 58 (04)
  • [16] Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?
    Huang, Ying
    Lin, Weiji
    Chen, Zhe
    Wang, Yu
    Huang, Yao
    Tu, Shenghao
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 2111 - 2124
  • [17] Novel pathways that regulate tumor necrosis factor-α production in rheumatoid arthritis
    Gracie, JA
    Leung, BP
    McInnes, IB
    CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (03) : 270 - 275
  • [18] Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis
    Al-Aly, Ziyad
    Pan, Hui
    Zeringue, Angelique
    Xian, Hong
    Mcdonald, Jay R.
    El-Achkar, Tarek M.
    Eisen, Seth
    TRANSLATIONAL RESEARCH, 2011, 157 (01) : 10 - 18
  • [19] Reduced Cardiovascular Risk with Use of Methotrexate and Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis.
    Bozaite-Gluosniene, Rasa
    Tang, Xiaoqin
    Kirchner, H. Lester
    Antohe, Jana L.
    Morris, Stephanie J.
    Wasko, Mary Chester
    Bili, Androniki
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S279 - S280
  • [20] Potentiated Antibodies to Tumor Necrosis Factor-α in the Therapy of Patients with Rheumatoid Arthritis
    L. V. Kozlovskaya
    N. A. Mukhin
    V. V. Rameev
    I. A. Sarkisova
    O. I. Epstein
    Bulletin of Experimental Biology and Medicine, 2003, 135 (Suppl 7) : 152 - 154
12345